SENSEX 76,728.38
+ 668.61
NIFTY 23,964.00
+ 196.55
CRUDEOIL 8,120.00
AstraZeneca beats Q2 profit expectations, holds outlook
The company’s core earnings for the three months ended June 30 rose 18% to $2.63 per share, while total revenue jumped 5% to $15.38 billion at constant-currency rates.
TL;DRAI
AstraZeneca's Q2 earnings jumped 18% to $2.63 per share, beating consensus on cancer and rare-disease demand. A recent trial failure threatens pipeline, yet guidance hold signals management confidence in current blockbusters—key for assessing long-term growth sustainability amid innovation risks.
272 words~1 min read
